Funding for this research was provided by:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR044031)
Canadian Institutes of Health Research (FDN-148387)
Received: 3 September 2020
Accepted: 6 December 2020
First Online: 4 January 2021
Change Date: 8 January 2021
Change Type: Update
Change Details: Previous ESM file contains track changes. Replacement ESM file has been uploaded..
Ethics approval and consent to participate
: This study was approved by the Ottawa Hospital Research Ethics Board under the protocol number 20150544-01H.
: Not applicable.
: M.A.R is CSO and Founder of Satellos Bioscience. P.F. and E.T. declare no competing interests.